Biogen stops Phase 2 study in another hit to 'high-risk' pipeline

Biogen stops Phase 2 study in another hit to 'high-risk' pipeline

Submitted by admin on September 17, 2019 - 3:38pm
Source: 
Biopharma Dive
News Tags: 
Biogen
clinical trials
IPF
idiopathic pulmonary fibrosis
BG00011
Headline: 
Biogen stops Phase 2 study in another hit to 'high-risk' pipeline
snippet: 

Biogen confirmed Tuesday it ended a Phase 2b study early for an experimental treatment for idiopathic pulmonary fibrosis, or IPF, citing safety concerns with the drug.

Do Not Allow Advertisers to Use My Personal information